Literature DB >> 22948089

Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament.

Ales Bartos1, Lenka Fialová, Jana Svarcová, Daniela Ripova.   

Abstract

The role of humoral immunity related to neuron- and disease-specific cytoskeletal proteins patients with Alzheimer disease (AD) is unknown. We measured antibodies against tau protein, light and heavy (NFH) neurofilaments using ELISA in 80 paired serum and cerebrospinal fluid (CSF) samples from patients with AD, with other dementias (OD), with neuro-inflammatory diseases (IC) and 25 controls (NC). We estimated intrathecal synthesis according to the formula (CSF/serum anti-neurocytoskeletal IgG)/(CSF/serum total IgG). AD patients had significantly higher intrathecal anti-tau and anti-NFH antibodies than the other groups. These innovative findings may hint at specific alterations in humoral anti-neurocytoskeletal immunity and selectivity in AD, which could have diagnostic and immunotherapeutic implications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948089     DOI: 10.1016/j.jneuroim.2012.08.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.

Authors:  Zhong-Yuan Yu; Wei-Wei Li; Hai-Mei Yang; Noralyn B Mañucat-Tan; Jun Wang; Ye-Ran Wang; Bin-Lu Sun; Zi-Cheng Hu; Li-Li Zhang; Liang Tan; Juan Deng; Yu-Hui Liu
Journal:  Neurotox Res       Date:  2020-02-05       Impact factor: 3.911

Review 2.  Review on intermediate filaments of the nervous system and their pathological alterations.

Authors:  Claire Lépinoux-Chambaud; Joël Eyer
Journal:  Histochem Cell Biol       Date:  2013-06-08       Impact factor: 4.304

3.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Authors:  Cecilia S Lindestam Arlehamn; John Pham; Roy N Alcalay; April Frazier; Evan Shorr; Chelsea Carpenter; John Sidney; Rekha Dhanwani; Julian Agin-Liebes; Francesca Garretti; Amy W Amara; David G Standaert; Elizabeth J Phillips; Simon A Mallal; Bjoern Peters; David Sulzer; Alessandro Sette
Journal:  J Immunol       Date:  2019-05-13       Impact factor: 5.422

Review 4.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

5.  Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.

Authors:  Kasandra Burgos; Ivana Malenica; Raghu Metpally; Amanda Courtright; Benjamin Rakela; Thomas Beach; Holly Shill; Charles Adler; Marwan Sabbagh; Stephen Villa; Waibhav Tembe; David Craig; Kendall Van Keuren-Jensen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

6.  Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.

Authors:  Yannick Kronimus; Alexandra Albus; Monika Balzer-Geldsetzer; Sarah Straub; Elisa Semler; Markus Otto; Jens Klotsche; Richard Dodel; David Mengel
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

Review 7.  Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications.

Authors:  Jianming Wu; Ling Li
Journal:  J Biomed Res       Date:  2016-01-02

8.  Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Alessandro Fiorentini; Francesco Ursini; Alessandro Martorana; Giacomo Koch; Lorena Belli; Sofia Toniolo; Barbara Di Pietro; Caterina Motta; Orazio Schillaci
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

9.  Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory study.

Authors:  Andrea C Klaver; Mary P Coffey; David A Bennett; David A Loeffler
Journal:  Transl Neurodegener       Date:  2017-11-24       Impact factor: 8.014

10.  High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.

Authors:  Sarah Doss; Klaus-Peter Wandinger; Bradley T Hyman; Jessica A Panzer; Matthis Synofzik; Bradford Dickerson; Brit Mollenhauer; Clemens R Scherzer; Adrian J Ivinson; Carsten Finke; Ludger Schöls; Jennifer Müller Vom Hagen; Claudia Trenkwalder; Holger Jahn; Markus Höltje; Bharat B Biswal; Lutz Harms; Klemens Ruprecht; Ralph Buchert; Günther U Höglinger; Wolfgang H Oertel; Marcus M Unger; Peter Körtvélyessy; Daniel Bittner; Josef Priller; Eike J Spruth; Friedemann Paul; Andreas Meisel; David R Lynch; Ulrich Dirnagl; Matthias Endres; Bianca Teegen; Christian Probst; Lars Komorowski; Winfried Stöcker; Josep Dalmau; Harald Prüss
Journal:  Ann Clin Transl Neurol       Date:  2014-10-18       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.